首页> 外文期刊>Biomedical Research on Trace Elements >Platimun Compounds Involving New Anti-cancer Mechanism
【24h】

Platimun Compounds Involving New Anti-cancer Mechanism

机译:涉及新抗癌机制的铂化合物

获取原文
       

摘要

Cisplatin, clinically used anticancer Pt(II) complex, has been believed to attack DNA to form Pt-N7(Guanine) coordination, and Pt-G bond is protected from DNA repair enzyme by the aromatic ring stacking between Pt-G and Phe side chain in Pt-DNA-HMG protein adduct. The adduct mimicked 4N coordinated Pt(II) complexes M(DA)(AtCn) involving with metal coordinated aromatic diamine (DA) and anthracene ring side chain in AtCn, which could not coordinate DNA, showed not only in vitro cytotoxicity for human cancer cell lines but also strong inhibition with protein interaction such as the proteasome. The bio-activity indicated the structural dependence of both DA and AtCn. This should relate with the intramolecular aromatic ring stacking interaction which was evidenced by the X-ray structure in crystal and the H-1 NMR in H_(2)O solution. Importantly the Pt(II) complexes showed similar bioactivity in cisplatin resistance cancer cell. These experimental results showed that the Pt complexes involving stacking structure might be new type anticancer metal compounds.
机译:顺铂是临床上使用的抗癌Pt(II)复合物,据信会攻击DNA以形成Pt-N7(Guanine)配位,并且Pt-G和Phe侧之间的芳香环堆积可保护Pt-G键免受DNA修复酶的破坏。 Pt-DNA-HMG蛋白加合物中的链。该加合物模仿了4N配位的Pt(II)配合物M(DA)(AtCn),与AtCn中的金属配位的芳族二胺(DA)和蒽环侧链有关,无法协调DNA,不仅显示出对人类癌细胞的体外细胞毒性品系,但也具有与蛋白质相互作用的强烈抑制作用,例如蛋白酶体。生物活性表明DA和AtCn的结构依赖性。这应该与分子内的芳环堆积相互作用有关,这由晶体中的X射线结构和H_(2)O溶液中的H-1 NMR证明。重要的是,Pt(II)复合物在顺铂耐药癌细胞中显示出相似的生物活性。这些实验结果表明,涉及堆积结构的铂络合物可能是新型的抗癌金属化合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号